Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Saved in:
| Title: | Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis. |
|---|---|
| Authors: | Volpato M; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Perry SL; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Marston G; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Ingram N; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Cockbain AJ; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Burghel H; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Mann J; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Lowes D; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Wilson E; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Droop A; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom.; MRC Medical Bioinformatics Centre, University of Leeds, Leeds, LS2 9NL, UK., Randerson-Moor J; Leeds Institute of Cancer Studies and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Coletta PL; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom., Hull MA; Leeds Institute of Biomedical & Clinical Sciences, Wellcome Trust Brenner Building, St James's University Hospital, Leeds LS9 7TF, United Kingdom. |
| Source: | Oncotarget [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 28139-50. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
